首页 | 本学科首页   官方微博 | 高级检索  
     

诺维本为主的联合方案治疗晚期乳腺癌
引用本文:季楚舒,胡冰,庄建生. 诺维本为主的联合方案治疗晚期乳腺癌[J]. 中国基层医药, 2002, 9(10): 874-875
作者姓名:季楚舒  胡冰  庄建生
作者单位:230001,合肥,安徽省立医院肿瘤科
摘    要:目的 观察以诺维本为主的联合方案治疗晚期难治性乳腺癌的疗效。方法 应用诺维本为主的联合方案治疗晚期难治性乳腺癌28例。结果 28例病人有效率为53.2%,毒副反应主要为骨髓抑制。结论 以诺维本为主的联合方案治疗晚期难治性乳腺癌的疗效较好且大多数病人均能耐受。

关 键 词:NVB 药物治疗 晚期乳腺癌 毒副反应 诺维本
修稿时间:2002-08-24

Clinical observation of NVB-contained chemotherapeutic regimen in advanced breast cancer
JI Chushu,HU Bing,ZHUANG Jiansheng. Clinical observation of NVB-contained chemotherapeutic regimen in advanced breast cancer[J]. Chinese Journal of Primary Medicine and Pharmacy, 2002, 9(10): 874-875
Authors:JI Chushu  HU Bing  ZHUANG Jiansheng
Affiliation:JI Chushu,HU Bing,ZHUANG Jiansheng.Department of Medical Oncology,Anhui Provincial Hospital,Hefei,230001,China
Abstract:Objective To observe the antitumor efficacy of NVB(navelbine)-contained chemotherapeutic regimens in advanced treast cancer.Methods Twenty-eight patients of advanced breast cancer were treated with combination chemotherapy of NVB.Results Twenty-eight patients were evaluated for efficacy and toxicity.The overall response rate was 53.2% and the complete response rate was 7.1%(2/28).The main toxic effect was bone marrow suppression.Conclusion NVB-contained chemotherapeutic regimen are effective and tolerable for advanced breast cancer.
Keywords:Navelbine Drug therapy Breast cancer Toxicity
本文献已被 CNKI 维普 万方数据 等数据库收录!
设为首页 | 免责声明 | 关于勤云 | 加入收藏

Copyright©北京勤云科技发展有限公司  京ICP备09084417号